Leukocyte adhesion deficiency syndrome: A controversy solved

Immunology and Cell Biology

Volumn 87, Issue 6, 2009, Pages 440-442

  Abram, Clare L ^a   Lowell, Clifford A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; CD15 ANTIGEN; INTEGRIN RECEPTOR; MESSENGER RNA; RAP1 PROTEIN;

CALDAG GEF1 GENE; GENE; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; KINDLIN 1 GENE; LEUKOCYTE; LEUKOCYTE ADHESION DEFICIENCY; NOTE;

ACTINS; ALLOSTERIC REGULATION; BLOOD PLATELETS; CELL ADHESION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTEGRIN BETA CHAINS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; LEUKOCYTES; MEMBRANE PROTEINS; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 69049110868     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.32     Document Type: Note

References (14)

1. Kuijpers TW, van de Vijver E, Weterman MA, de Boer M, Tool AT, van den Berg TK et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood (e-pub ahead of print 8 December 2008; doi:10.1182/blood-2008-10-182154).
2. Malinin NL, Zhang L, Choi J, Ciocea A, Razorenova O, Ma YQ et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009; 15: 313-318.
3. Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009; 15: 306-312.
4. Etzioni A. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options. Adv Exp Med Biol 2007; 601: 51-60.
5. Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Ann Rev Immunol 2009; 27: 339-362.
6. Pasvolsky R, Feigelson SW, Kilic SS, Simon AJ, Tal-Lapidot G, Grabovsky V et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 2007; 204: 1571-1582. (Pubitemid 47048024)
7. Alon R, Aker M, Feigelson S, Sokolovsky-Eisenberg M, Staunton DE, Cinamon G et al. A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 2003; 101: 4437-4445. (Pubitemid 36857810)
8. Kilic SS, Etzioni A. The clinical spectrum of leukocyte adhesion deficiency (LAD) III due to defective CalDAGGEF1. J Clin Immunol 2009; 29: 117-122.
9. Bergmeier W, Goerge T, Wang HW, Crittenden JR, Baldwin AC, Cifuni SM et al. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 2007; 117: 1699-1707. (Pubitemid 46871354)
10. Kuijpers TW, van Bruggen R, Kamerbeek N, Tool AT, Hicsonmez G, Gurgey A et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood 2007; 109: 3529-3537. (Pubitemid 46572546)
11. Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhan GI, Gershoni-Baruch R et al. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 2008; 112: 2591.
12. Larjava H, Plow EF, Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep 2008; 9: 1203-1208.
13. Ussar S, Moser M, Widmaier M, Rognoni E, Harrer C, Genzel-Boroviczeny O et al. Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet 2008; 4: e1000289.
14. Moser M, Bauer M, Schmid S, Ruppert R, Schmidt S, Sixt M et al. Kindlin-3 is required for b2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med 2009; 15: 300-305.